DoseSpot
PrivateLast Round
M&A
Mar 2, 2026
Total Funding Raised
$25,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DoseSpot operates in Healthcare & Life Sciences and is based in Dedham, Massachusetts. Its latest recorded funding round was a Growth Equity round in January 2022.
DoseSpot is a healthcare technology company that provides e-prescribing, insurance verification, and revenue cycle management software solutions for healthcare providers.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Vertical SaaS, Telemedicine, Compliance
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DoseSpot Comparables
Compare DoseSpot with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MDToolbox | 83% | |
| D.A.W. Systems, Inc. | 79% | |
| Photon Health | 79% |
For institutional investors. Book with your work email.
DoseSpot Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Mar 2, 2026 | ||||
| Growth Equity | Jan 26, 2022 | ||||
| Grant | May 1, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DoseSpot Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Providence Strategic Growth | M&A, Growth Equity |
| UPMC Enterprises | M&A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Funding round led by Bain Capital Tech Opportunities.
- Jan 26, 2022
Providence Strategic Growth led the round.
For institutional investors. Book with your work email.
DoseSpot Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DoseSpot's valuation, stock price, and market status.
Is DoseSpot a public or private company?
DoseSpot is a private company.
What is the current stock price of DoseSpot?
DoseSpot is a private company, so its shares have no public market price. Caplight tracks DoseSpot's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DoseSpot worth (valuation)?
Valuation information for DoseSpot is not publicly available.
Can I buy DoseSpot stock?
DoseSpot shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DoseSpot's last funding round?
DoseSpot's most recent funding round was M&A on March 2, 2026.
Who are the main investors in DoseSpot?
Key investors in DoseSpot include Providence Strategic Growth.
Will DoseSpot IPO soon?
No public IPO plans have been announced for DoseSpot.
How can I track DoseSpot secondary market activity?
Caplight tracks bids, offers, and trades in DoseSpot's shares on secondary markets.